Professor | Huabing Li | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Huabing Li
Contact Information	huabing.li@yale.edu
Language ability	English, Chinese
Province	Chongqing

Upload Avatar (500 x 500)

Name

Huabing Li

Contact Information

huabing.li@yale.edu

Language ability

English, Chinese

Province

Chongqing

University/Lab Affiliation and Title	Chongqing Medical University
Faculty	Basic Medical Sciences
Academic Background & Achievements	2012-2017 Postdoctoral: Yale University 2011-2012 Postdoctoral: Rutgers University 2005-2011 Ph.D.: Rutgers University 2002-2005 M.S.: Nankai University 1999-2002 B.S.: Nankai University Published in top journals like Nature, Nature Immunology, and Science Advances
Work Experience	2024-present - Chongqing Medical University - Professor 2022.3-present - Ruijin Hospital, Shanghai Jiao Tong University School of Medicine - Distinguished Professor 2020.5-present - State Key Laboratory of Oncogenes and Related Genes - Principal Investigator 2019.5-present - Shanghai Jiao Tong University School of Medicine-Yale University Institute of Immunometabolism - Researcher 2017.8-present - Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine - Senior Researcher, Doctoral Supervisor; Yale University School of Medicine - Assistant Professor Adjunct
Awards	National Science Fund for Distinguished Young Scholars (2023) Shanghai Health Leading Talent (2022) National High-level Overseas Talent Youth Project (2018) Shanghai 'Oriental Scholar' Distinguished Professor (2018)

University/Lab Affiliation and Title

Chongqing Medical University

Faculty

Basic Medical Sciences

Academic Background & Achievements

2012-2017 Postdoctoral: Yale University
2011-2012 Postdoctoral: Rutgers University
2005-2011 Ph.D.: Rutgers University
2002-2005 M.S.: Nankai University
1999-2002 B.S.: Nankai University
Published in top journals like Nature, Nature Immunology, and Science Advances

Work Experience

2024-present - Chongqing Medical University - Professor
2022.3-present - Ruijin Hospital, Shanghai Jiao Tong University School of Medicine - Distinguished Professor
2020.5-present - State Key Laboratory of Oncogenes and Related Genes - Principal Investigator
2019.5-present - Shanghai Jiao Tong University School of Medicine-Yale University Institute of Immunometabolism - Researcher
2017.8-present - Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine - Senior Researcher, Doctoral Supervisor; Yale University School of Medicine - Assistant Professor Adjunct

Awards

National Science Fund for Distinguished Young Scholars (2023)
Shanghai Health Leading Talent (2022)
National High-level Overseas Talent Youth Project (2018)
Shanghai 'Oriental Scholar' Distinguished Professor (2018)

Areas of Focus	RNA Modifications and Epigenetic Immunity
Publications	A Treg specific long non-coding RNA maintains immune-metabolic homeostasis in ageing liver., Ding C, Yu Z, Sefik E, Zhou J, Kaffe E, Wang G, Li B, Flavell RA, Hu W, Ye Y, Li HB, 2023 tRNA-m1A modification promotes T cell expansion via efficient MYC protein synthesis., Liu Y, Zhou J, Li X, Zhang X, Shi J, Wang X, Li H, Miao S, Chen H, He X, Dong L, Lee GR, Zhen J, Liu RJ, Su B, Ye Y, Flavell RA, Yi C, Wu Y, Li HB, 2022 RNA m6A demethylase ALKBH5 regulates the development of γδ T cells., Ding C, Xu H, Yu Z, Roulis M, Qu R, Zhou J, Oh J, Crawford J, Gao Y, Jackson R, Sefik E, Li S, Wei Z, Skadow M, Yin Z, Ouyang X, Wang L, Zou Q, Su B, Hu W, Flavell R, Li HB, 2022 DENR controls JAK2 translation to induce PD-L1 expression for tumor immune evasion., Chen B, Hu J, Chen H, Bao R, Zhou Y, Zhan M, Ye Y, Li H, Li HB, 2022 m6A mRNA modification maintains colonic epithelial cell homeostasis via NF-κb-mediated anti-apoptotic pathway., Zhang T, Ding C, Chen H, Zhao J, Chen J, Chen B, Mao K, Hao Y, Roulis M, Xu H, Kluger Y, Zou Q, Ye Y, Zhan M, Flavell RA, Li HB, 2022 m6A Demethylase ALKBH5 Controls CD4+ T cell Pathogenicity and Promotes Autoimmunity., Zhou J, Zhang X, Hu J, Qu R, Yu Z, Xu H, Chen H, Yan L, Ding C, Zou Q, Ye Y, Wang Z, Flavell RA, Li HB, 2021 Pooled CRISPR Screening Identifies m6A as a Positive Regulator of Macrophage Activation., Tong J, Wang X, Liu Y, Ren X, Wang A, Chen Z, Yao J, Mao K, Liu T, Meng FL, Pan W, Zou Q, Zhou Y, Xia Q, Flavell RA, Zhu S, Li HB, 2021 Cross-talk of Four Types of RNA Modification Writers Defines Tumor Microenvironment and Pharmacogenomic Landscape in Colorectal Cancer., Chen H, Yao J, Bao R, Dong Y, Zhang T, Du Y, Wang G, Ni D, Xun Z, Niu X, Ye Y, Li HB, 2021 m6A mRNA methylation sustains Treg suppressive functions., Tong J, Cao G, Zhang T, Sefik E, Vesely M, Broughton J, Zhu S, Li H, Li B, Chen L, Chang HY, Su B, Flavell RA, Li HB, 2018 m6A mRNA methylation controls T cell homeostasis by targeting IL-7/STAT5/SOCS pathway., Li HB, Tong J, Zhu S, Batista PJ, Duffy EE, Zhao J, Bailis W, Cao G, Kroehling L, Chen Y, Wang G, Broughton JP, Chen YG, Kluger Y, Simon MD, Chang HY, Yin Z, Flavell RA, 2017

Areas of Focus

RNA Modifications and Epigenetic Immunity

Publications

A Treg specific long non-coding RNA maintains immune-metabolic homeostasis in ageing liver., Ding C, Yu Z, Sefik E, Zhou J, Kaffe E, Wang G, Li B, Flavell RA, Hu W, Ye Y, Li HB, 2023
tRNA-m1A modification promotes T cell expansion via efficient MYC protein synthesis., Liu Y, Zhou J, Li X, Zhang X, Shi J, Wang X, Li H, Miao S, Chen H, He X, Dong L, Lee GR, Zhen J, Liu RJ, Su B, Ye Y, Flavell RA, Yi C, Wu Y, Li HB, 2022
RNA m6A demethylase ALKBH5 regulates the development of γδ T cells., Ding C, Xu H, Yu Z, Roulis M, Qu R, Zhou J, Oh J, Crawford J, Gao Y, Jackson R, Sefik E, Li S, Wei Z, Skadow M, Yin Z, Ouyang X, Wang L, Zou Q, Su B, Hu W, Flavell R, Li HB, 2022
DENR controls JAK2 translation to induce PD-L1 expression for tumor immune evasion., Chen B, Hu J, Chen H, Bao R, Zhou Y, Zhan M, Ye Y, Li H, Li HB, 2022
m6A mRNA modification maintains colonic epithelial cell homeostasis via NF-κb-mediated anti-apoptotic pathway., Zhang T, Ding C, Chen H, Zhao J, Chen J, Chen B, Mao K, Hao Y, Roulis M, Xu H, Kluger Y, Zou Q, Ye Y, Zhan M, Flavell RA, Li HB, 2022
m6A Demethylase ALKBH5 Controls CD4+ T cell Pathogenicity and Promotes Autoimmunity., Zhou J, Zhang X, Hu J, Qu R, Yu Z, Xu H, Chen H, Yan L, Ding C, Zou Q, Ye Y, Wang Z, Flavell RA, Li HB, 2021
Pooled CRISPR Screening Identifies m6A as a Positive Regulator of Macrophage Activation., Tong J, Wang X, Liu Y, Ren X, Wang A, Chen Z, Yao J, Mao K, Liu T, Meng FL, Pan W, Zou Q, Zhou Y, Xia Q, Flavell RA, Zhu S, Li HB, 2021
Cross-talk of Four Types of RNA Modification Writers Defines Tumor Microenvironment and Pharmacogenomic Landscape in Colorectal Cancer., Chen H, Yao J, Bao R, Dong Y, Zhang T, Du Y, Wang G, Ni D, Xun Z, Niu X, Ye Y, Li HB, 2021
m6A mRNA methylation sustains Treg suppressive functions., Tong J, Cao G, Zhang T, Sefik E, Vesely M, Broughton J, Zhu S, Li H, Li B, Chen L, Chang HY, Su B, Flavell RA, Li HB, 2018
m6A mRNA methylation controls T cell homeostasis by targeting IL-7/STAT5/SOCS pathway., Li HB, Tong J, Zhu S, Batista PJ, Duffy EE, Zhao J, Bailis W, Cao G, Kroehling L, Chen Y, Wang G, Broughton JP, Chen YG, Kluger Y, Simon MD, Chang HY, Yin Z, Flavell RA, 2017

Rna Modifications Epigenetics Immunity Immune Cells Molecular Mechanisms Pathophysiology Regulation Cell Function Research

Shang Yongfeng - Peking University

Kong Wei - Peking University

Genze Shao - Peking University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us